Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,596 | 61,813 | 15,378 | 4,741 | 564 |
| Marketable Securities | N/A | N/A | 7,577 | N/A | N/A |
| Receivables | 793 | 1,354 | 1,336 | 254 | N/A |
| TOTAL | $43,389 | $63,167 | $24,291 | $4,995 | $566 |
| Non-Current Assets | |||||
| PPE Net | 6,841 | 4,506 | 2,404 | 2,035 | N/A |
| Other Non-Current Assets | 581 | 464 | 293 | 195 | 0 |
| TOTAL | $7,422 | $4,970 | $2,697 | $2,230 | $N/A |
| Total Assets | $50,811 | $68,137 | $26,988 | $7,225 | $566 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,527 | 3,762 | 2,268 | 845 | 4 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 66 |
| TOTAL | $5,527 | $3,762 | $2,268 | $845 | $71 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 937 | 690 | 436 | 285 | 0 |
| TOTAL | $937 | $690 | $436 | $285 | $N/A |
| Total Liabilities | $6,464 | $4,452 | $2,704 | $1,130 | $71 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,594 | 7,586 | 6,566 | 58 | 29 |
| Common Shares | 76 | 76 | 62 | 19 | 0 |
| Retained earnings | -75,010 | -52,596 | -20,512 | -11,122 | -3,738 |
| Other shareholders' equity | 0 | 0 | 355 | 1,028 | 0 |
| TOTAL | $44,347 | $63,685 | $24,284 | $6,095 | $495 |
| Total Liabilities And Equity | $50,811 | $68,137 | $26,988 | $7,225 | $566 |